CATEGORY: REGULATORY PATHWAYS

Humanitarian Device Exemption (HDE)

An FDA pathway for devices intended to treat or diagnose conditions affecting fewer than 8,000 patients per year in the US. HDE does not require effectiveness data but requires probable benefit.

Last reviewed 2026-08-05 · Reviewed by MedFlux Editorial Board · Editorial policy

WHEN IT APPLIES

Humanitarian Device Exemption covers devices treating/diagnosing conditions affecting fewer than 8,000 patients/year in the US, with probable benefit rather than full effectiveness proof.

PROCESS / STEPS

Confirm rare-condition population estimate.
Prepare HDE application and IRB considerations for use.
Plan post-approval reporting and HUD limitations on profit in some cases.

EXAMPLES

Devices for ultra-rare pediatric conditions may use HDE when PMA is impractical.

RELATED GUIDES & TOOLS

SOURCES

FDA HDE ↗

Track regulatory signals related to Humanitarian Device Exemption (HDE) across 27 authorities in real time.

START FREE →